This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Neurogenetics  • Pediatric Neurology  • Neurology, Other  • Pediatrics  • Pediatrics, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Maryam Oskoui, MD; Guido Davidzon, MD; Juan Pascual, MD, PhD; Ricardo Erazo, MD; Juliana Gurgel-Giannetti, MD; Sindu Krishna, MD; Eduardo Bonilla, MD; Darryl C. De Vivo, MD; Sara Shanske, PhD; Salvatore DiMauro, MD

Arch Neurol. 2006;63:1122-1126.

Background  Mitochondrial DNA depletion syndrome is an autosomal recessive disorder characterized by decreased mitochondrial DNA copy numbers in affected tissues. It has been linked to 4 genes involved in deoxyribonucleotide triphosphate metabolism: thymidine kinase 2 (TK2), deoxyguanosine kinase (DGUOK), polymerase gamma (POLG), and SUCLA2, the gene encoding the -subunit of the adenosine diphosphate–forming succinyl coenzyme A synthetase ligase.

Objective  To highlight the variability in the clinical spectrum of TK2-related mitochondrial DNA depletion syndrome.

Design  Review of patients and the literature.

Setting  Tertiary care university.

Patients  Four patients with mitochondrial DNA depletion syndrome and mutations in the TK2 gene.

Main Outcome Measures  Definition of clinical variability.

Results  Patient 1 had evidence of lower motoneuron disease and was initially diagnosed as having spinal muscular atrophy type 3. Patient 2, who is alive and ambulatory at age 9 years, presented at age 2 years with a slowly progressive mitochondrial myopathy. Patient 3 had a more severe myopathy, with onset in infancy and death at age 6 years of respiratory failure. Patient 4 had a rapidly progressive congenital myopathy with rigid spine syndrome and he died at age 19 months.

Conclusion  The clinical spectrum of TK2 mutations is not limited to severe infantile myopathy with motor regression and early death but includes spinal muscular atrophy type 3–like presentation, rigid spine syndrome, and subacute myopathy without motor regression and with longer survival.

Author Affiliations: Department of Neurology, Columbia University Medical Center, New York, NY (Drs Oskoui, Davidzon, Pascual, Krishna, Bonilla, De Vivo, Shanske, and DiMauro); Division of Pediatric Neurology, Hospital Luis Calvo MacKenna, Santiago, Chile (Dr Erazo); and Department of Pediatrics, Federal University of Minas Gerais, Belo Horizonte, Brazil (Dr Gurgel-Giannetti).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome
Gotz et al.
Brain 2008;131:2841-2850.
ABSTRACT | FULL TEXT  

Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance
Akman et al.
Hum Mol Genet 2008;17:2433-2440.
ABSTRACT | FULL TEXT  

Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice
Zhou et al.
Hum Mol Genet 2008;17:2329-2335.
ABSTRACT | FULL TEXT  

Amyotrophic Lateral Sclerosis With Ragged-Red Fibers
Hirano et al.
Arch Neurol 2008;65:403-406.
ABSTRACT | FULL TEXT  

Mutations in SUCLA2: a tandem ride back to the Krebs cycle
Chinnery
Brain 2007;130:606-609.
FULL TEXT